COG AALL1731 - A Phase 3 Trial Investigating Blinatumomab (IND# 117467, NSC# 765986) in Combination with Chemotherapy in Patients with Newly Diagnosed Standard Risk or Down syndrome B-Lymphoblastic Leukemia (B-ALL) and the Treatment of Patients with Localized B-Lymphoblastic Lymphoma (B-LLy)
![](https://researchstudies.cuanschutz.edu/Content/images/study-category-images/cancer.jpg)
Details
Age
Child
Locations
Childrens Hospital Colorado
Principal Investigator
![Photograph of KELLY MALONEY](https://som.ucdenver.edu/FIMS/Content/faculty/12835/CU-Doctors-12835.jpg)
KELLY MALONEY
Study ID
Protocol Number: 19-1634
More information available at ClinicalTrials.gov: NCT03914625
Categories
Is this Study for You?
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers